24.07.2008
GLYCOTOPE GmbH erwirbt GMP-Produktionsstätte der ORPEGEN GmbH
GLYCOTOPE GmbH erwirbt GMP-Produktionsstätte der ORPEGEN in Heidelberg
Details

14.05.2008
CoreOptics announces closing of $25 million funding round
CoreOptics Inc. today announced the closure of a $25 million round of financing from existing investors, bringing the company’s total funding to date to more than $90 million.
Details

17.03.2008
Robowatch liefert Sicherheitsroboter für Olympia 2008
Die Robowatch GmbH liefert Sicherheitsroboter zu den olympischen Spielen 2008 nach Peking.
Details

25.02.2008
CoreOptics introduces MLSE-2 distortion equalization technology
CoreOptics introduces MLSE-2 distortion equalization technology for next generation of metro/regional optical networks
Details

06.11.2007
Axxonis Pharma AG, Berlin, obtains financing with ETV Capital .
Axxonis Pharma AG, Berlin, obtains financing with ETV Capital .

Details

29.10.2007
Niel Ransom joins CoreOptics board of directors
CoreOptics, the global leader in design and manufacturing of 40Gbps and 10Gbps optical networking subsystems, today announced that Alcatel optical veteran, Dr. Niel Ransom has joined the company's board of directors as an independent member.
Details

19.09.2007
Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
Details

17.09.2007
Imedos GmbH sichert sich weitere Finanzierung
Imedos GmbH sichert sich weitere Finanzierung
Details

17.09.2007
CoreOptics delivers fast-service-activation for metro optical networks
CoreOptics delivers fast-service-activation for metro optical networks
Details

29.08.2007
Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
Expanded Clinical Program Supported by Promising Results from Completed Trial
Details

13.08.2007
Follow on investment in PMG Aerospace; HTB became majority shareholder
HighTech Private Equity's investment fund HighTech Beteiligungen (HTB) together with the existing bank consortium invested an undisclosed amount in the aerospace company PMG Aerospace Industry AG, Hamburg (www.pmg.ag).
Details

02.07.2007
Axxonis Pharma AG: Zukunftsweisende Ergebnisse in der RLS-Forschung
Die Axxonis Pharma AG in Berlin wird für ihr Lisurid-Pflaster Leovan® 5 µg/h TDS auf Grund guter klinischer Ergebnisse auch beim Restless-Legs-Syndrom noch in diesem Jahr eine europäische Zulassung beantragen.
Details